Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

RDW

Redwire Receives Regulatory Approval for Edge Autonomy Acquisition

Redwire Corporation (NYSE: RDW) has announced that it has received all regulatory approvals required to complete its acquisition of Edge Autonomy. These approvals include the completion of the antitrust review under the Hart-Scott-Rodino Act in the United States, as well as foreign investment reviews in Latvia, Canada, and the United Kingdom.

The transaction is expected to close in the second quarter of 2025, subject to final closing conditions, including approval of Redwire’s stockholders.

Redwire also mentioned that it will file a proxy statement with the SEC relating to a special meeting of Redwire’s stockholders. Stockholders are encouraged to carefully read the proxy statement and any other relevant documents to be filed with the SEC in their entirety as they will contain important information about Redwire, Edge Autonomy, the transaction, and related matters.

Information about Redwire's directors and executive officers can be found in Redwire’s annual report on Form 10-K for the year ended December 31, 2024, and its proxy statement on Schedule 14A, dated April 22, 2024, which are filed with the SEC.

No specific financial metrics or changes since the last period were provided in this press release. As a result of these announcements, the company's shares have moved 1.6% on the market, and are now trading at a price of $11.47. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS